News tagged with hematology
Researchers discover master regulator that drives majority of lymphoma
A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team, led by investigators at Weill Cornell ...
Cancer
May 13, 2013 |
5 / 5 (2) |
0
|
Study identifies possible new acute leukemia marker, treatment target
A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope (that is, cytogenetically normal ...
Cancer
May 13, 2013 |
not rated yet |
0
Engineered stem cells seek out, kill HIV in living organisms
(Medical Xpress) -- Expanding on previous research providing proof-of-principal that human stem cells can be genetically engineered into HIV-fighting cells, a team of UCLA researchers have now demonstrated ...
HIV & AIDS
Apr 12, 2012 |
4.8 / 5 (64) |
0
|
Bioengineered protein shows preliminary promise as new therapy for hemophilia
A genetically engineered clotting factor that controlled hemophilia in an animal study offers a novel potential treatment for human hemophilia and a broad range of other bleeding problems.
Genetics
Oct 23, 2011 |
not rated yet |
0
|
Key bone marrow protein identified as potential new leukemia treatment target
A new study on how the progression of acute lymphocytic leukemia (ALL) is influenced by the bone marrow environment has demonstrated for the first time that targeting a specialized protein known as osteopontin (OPN) may be ...
Cancer
Apr 15, 2013 |
not rated yet |
0
Leading leukemia experts: High leukemia treatment costs may be harming patients
The increasing cost of treatments for chronic myeloid leukemia (CML) in the United States has reached unsustainably high levels and may be leaving many patients under- or untreated because they cannot afford care, according ...
Cancer
Apr 25, 2013 |
not rated yet |
0
New blood thinner beats older drug for vein clots
(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, ...
Medications
Feb 20, 2013 |
4 / 5 (1) |
0
|
Spin and bias in published studies of breast cancer trials
Spin and bias exist in a high proportion of published studies of the outcomes and adverse side-effects of phase III clinical trials of breast cancer treatments, according to new research published in the cancer journal Annals of ...
Cancer
Jan 09, 2013 |
not rated yet |
0
|
Study showed oxaliplatin improved colon cancer patient survival
Stage III colon cancer patients in the general population who receive adjuvant treatment for the disease have an improved rate of survival when oxaliplatin is added to 5-fluorouracil (5FU), according to a study published ...
Cancer
Jan 20, 2012 |
not rated yet |
0
BMI and lean body mass decline after allogeneic HSCT
(HealthDay)—In survivors of childhood hematologic malignancies who have received allogeneic hematopoietic stem cell transplantation (alloHSCT), body mass index (BMI) decreases significantly, mainly due ...
Cancer
Oct 04, 2012 |
2 / 5 (1) |
0
Women respond better to the treatment of lymph gland cancer with antibodies than men
(Medical Xpress)—Women respond much better than men to the treatment of chronic follicular lymphoma with a monoclonal antibody that targets CD20 (rituximab). These are the findings of a multi-centre, Austria-wide ...
Cancer
Oct 10, 2012 |
5 / 5 (1) |
0
Type 2 diabetes linked to increased blood cancer risk
Patients with type 2 diabetes have a 20 percent increased risk of developing blood cancers, such as non-Hodgkin lymphoma, leukemia and myeloma, according to a new meta-analysis led by researchers at The Miriam Hospital. The ...
Cancer
Jun 05, 2012 |
5 / 5 (1) |
0
|
Novel brain tumor vaccine acts like bloodhound to locate cancer cells
A national clinical trial testing the efficacy of a novel brain tumor vaccine has begun at Wake Forest Baptist Medical Center, the only facility in the Southeast to participate.
Cancer
Jan 05, 2012 |
not rated yet |
0
|
Researcher pieces together AML prognosis puzzle
When patients suffering from Acute Myeloid Leukemia (AML) express high levels of the gene, MN1, an already aggressive leukemia is accelerated and shortens survival time. While that's a known fact, the mechanisms involved ...
Cancer
Oct 15, 2012 |
not rated yet |
0
|
Researchers study use of dasatinib for patients with high-risk MDS
Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia, ...
Cancer
Mar 21, 2013 |
not rated yet |
0
Hematology
Hematology, also spelled haematology, is the branch of biology (physiology), pathology, clinical laboratory, internal medicine, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of etiology, diagnosis, treatment, prognosis, and prevention of blood diseases. The lab work that goes into the study of blood is performed by a medical technologist.
Blood diseases affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, the mechanism of coagulation, etc.
Physicians specialized in hematology are known as hematologists. Their routine work mainly includes the care and treatment of patients with hematological diseases, although some may also work at the haematology laboratory viewing blood films and bone marrow slides under the microscope, interpreting various haematological test results. In some institutions, haematologists also manage the haematology laboratory. Physicians who work in haematology laboratories, and most commonly manage them, are pathologists specialized in the diagnosis of haematological diseases, referred to as haematopathologists. Haematologists and haematopathologists generally work in conjunction to formulate a diagnosis and deliver the most appropriate therapy if needed. Haematology is a distinct subspecialty of internal medicine, separate from but overlapping with the subspecialty of medical oncology. Haematologists may specialise further or have special interests, for example in:
only some blood disorders can be cured.
(Hematology comes from the Greek words ἁίμα (haima) meaning "blood" and λόγος (logos), a root commonly employed to denote a field of study.)
For more information about Hematology, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.